FDA Adverse Event Injury Summary report: N

TAPER SLEEVE ADAPTER 12/14 +2

MDR report key: 4212169 · Received October 29, 2014

Report

Report Number
1818910-2014-30907
Event Type
Injury
Date Received
October 29, 2014
Date of Event
February 8, 2011
Report Date
October 16, 2014
Manufacturer
DEPUY INTERNATIONAL LTD. 8010379
Product Code
KWA
Removal / Correction Number
Z-1749/1816-2011
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
SZ
Reporter Occupation
PATIENT

Narratives

Additional Manufacturer Narrative · 1

IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL MEDWATCH, A FOLLOW-UP MEDWATCH WILL BE FILED AS APPROPRIATE.NO 510(K) NUMBER PROVIDED BECAUSE THIS IMPLANT IS SOLD INTERNATIONALLY WITH DIFFERENT INDICATIONS FOR USE; IT IS CURRENTLY SOLD IN THE US UNDER A DIFFERENT PART NUMBER. THE CORRECTION/REMOVAL REPORTING NUMBER LISTED APPLIES TO THE CORRESPONDING PRODUCT CODE SOLD DOMESTICALLY. THE ASR PLATFORM WAS VOLUNTARILY RECALLED FROM THE MARKET IN AUGUST 2010, AND THE ASR PRODUCT CODES ARE NOW CONSIDERED INACTIVE. FURTHER INVESTIGATION OF THIS INDIVIDUAL INCIDENT WILL NOT BE UNDERTAKEN, AS THERE IS AN ONGOING INVESTIGATION REGARDING THE ROOT CAUSE(S) AND/OR CORRECTIVE ACTIONS. (B)(4). DEPUY CONSIDERS THE INVESTIGATION CLOSED AT THIS TIME. SHOULD THE PRODUCT AND/OR ADDITIONAL INFORMATION BE RECEIVED, THE INVESTIGATION WILL BE RE-OPENED.

Description of Event or Problem · 1

NEW ETQ RECORD CREATED IN ORDER TO UPDATE ETQ (LEGACY SYSTEM) COMPLAINT NUMBER DINT (B)(4) REASON FOR ORIGINAL COMPLAINT ¿ASR REVISION.ASR XL ACETABULAR SYSTEM - LEFT.REASON(S) FOR REVISION: PAIN.ORIGINAL SURGERY: (B)(6) 2007.REVISION SURGERY: (B)(6) 2011.UPDATE - ADDED SLEEVE AND STEM TAKEN FROM CLAIMSUITE DATED (B)(6) 2013.UPDATE - ADDED ADDITIONAL HOSPITAL. TAKEN FROM CLAIMSUITE DATED (B)(6) 2014

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
692031 TAPER SLEEVE ADAPTER 12/14 +2 HIP FEMORAL STEM/SLEEVE KWA DEPUY INTERNATIONAL LTD. 8010379 2364523

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention